LYEL
NASDAQ · Biotechnology
Lyell Immunopharma Inc
$14.71
+0.50 (+3.52%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+90.0% upside
Low Target
$18.45
Average Target
$27.95
High Target
$35.39
Current Price
$14.71
Current
$14.71
$14.71
Target
$27.95
$27.95
$18.45
$27.95 avg
$35.39
Scenario Analysis
Bear Case
$18.45
25.4%
Low target
Base Case
$27.95
+90.0%
Avg target
Bull Case
$35.39
+140.6%
High target
Risk/Reward
5.5x
Highly favorable
Price in Context
52-Week High
$45.00
-67.3% from high
52-Week Low
$9.28
+58.5% from low
Target vs 52W High
$27.95
-37.9% vs high
Next Earnings Report
Aug 10, 2026
Today
EPS Est: $-2.06
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |